New attempt for Moderna to reverse

16 february 2022 86
Volkov_Anton
Volkov_Anton

Listed among the best MarketCheese authors
1st in the segment "Currencies"
2nd in the segments "Indices", "US stocks" and "Metals"
Load the latest quotes
Full screen

Since August, Moderna stocks are in the strong downtrend. At the end of November, it was a surge in demand for shares of coronavirus vaccine manufacturers amid the emergence of “omicron” but it quickly came to nothing and the decline continued.


On 14 February, Moderna failed down by 12% after suspending approval of its vaccine for children under five.

An additional negative influence became a sell of company’s stocks by its CEO and the co-owner Stéphane Bancel of almost $3 mln.


The price tried to be below the strong support of 150 but buyers intensified on the next day and returned the quotes above 150.


The “harami” pattern materialized but it is not very convincing for the development of a strong bounce. If the next candlestick proves growth, the levels of 160 and 177.5 can be achieved. Nevertheless, for now it looks like a game against a strong downtrend thus it is necessary to act very carefully. 

Volkov_Anton
Volkov_Anton

Listed among the best MarketCheese authors
1st in the segment "Currencies"
2nd in the segments "Indices", "US stocks" and "Metals"
Comments
New Popular
Send
Commenting rules

Subscribe to our newsletter and stay up to date with all the news!